| Literature DB >> 27144179 |
Peng Zhou1, Maricela Robles-Murguia1, Deepa Mathew1, Giles E Duffield1.
Abstract
Inhibitor of DNA binding 2 (ID2) is a helix-loop-helix transcriptional repressor rhythmically expressed in many adult tissues. Our previous studies have demonstrated that Id2 null mice have sex-specific elevated glucose uptake in brown adipose tissue (BAT). Here we further explored the role of Id2 in the regulation of core body temperature over the circadian cycle and the impact of Id2 deficiency on genes involved in insulin signaling and adipogenesis in BAT. We discovered a reduced core body temperature in Id2-/- mice. Moreover, in Id2-/- BAT, 30 genes including Irs1, PPARs, and PGC-1s were identified as differentially expressed in a sex-specific pattern. These data provide valuable insights into the impact of Id2 deficiency on energy homeostasis of mice in a sex-specific manner.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27144179 PMCID: PMC4842059 DOI: 10.1155/2016/6785948
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Figure 1Sex-specific regulation of body temperature in Id2−/− mice. (a) Body temperature measurements of WT and Id2−/− male (left) and female (right) mice under normal temperature (upper panel) or thermoneutral temperature (lower panel) over 24 hrs. Values are mean ± SEM. Two-factor ANOVA was performed. ANOVAs revealed significantly lower body temperatures for both male and female Id2−/− mice compared to WT mice. The genotypic effect was independent of the prevailing ambient temperature. (b) Upper: regression analysis of body weight to body temperature of WT and Id2−/− mice under normal ambient temperature (left: male at ZT5.5 and ZT20.5; right: female at ZT5.5 and ZT17.5). Lower: regression analysis of body weight to body temperature of WT and Id2−/− mice under thermoneutral temperature conditions (left: male at ZT5.5 and ZT17.5; right: female at ZT5.5 and ZT17.5). Values are individual animal body temperatures and their respective measures of body mass. Note that no linear regression was found to be significant (n.s.), indicating that body mass does not predict body temperature for any group analyzed, examined under either 21°C or 30°C environmental temperatures.
Figure 2Brown Adipose tissue weight in Id2−/− mice. (a) Interscapular brown adipose tissue (iBAT) mass (g) from WT and Id2−/− mice. (b) Ratio of weight of iBAT tissue to total body mass from WT and Id2−/− mice. Values are mean ± SEM. Two-factor ANOVAs were performed followed by Tukey's post hoc tests, p < 0.01. No significant differences were observed between groups in the iBAT mass/body mass analysis.
Differentially expressed genes from insulin signaling pathway of Id2−/− mice. Genes with significant differences (p < 0.05) are shown in bold. Peak phase value (determined by Lomb-Scargle phase values within CIRCA) in circadian time (CT) is provided where gene was identified as a clock control gene. Rhythmic genes identified from CIRCA database of Mouse 1.OST Brown Adipose (Affymetrix).
| Insulin signaling array | Symbol | Refseq | All | Male | Female | Clock control gene-peak phase | |||
|---|---|---|---|---|---|---|---|---|---|
| Fold change |
| Fold change |
| Fold change |
| ||||
|
| |||||||||
| AE binding protein 1 |
| NM_009636 | 1.9 | 0.09 |
|
| — | ||
| Complement factor D (adipsin) |
| NM_013459 |
|
|
|
| — | ||
| Fructose bisphosphatase 1 |
| NM_019395 | 1.3 | 0.22 |
|
| — | ||
| Glucose-6-phosphatase, catalytic |
| NM_008061 | 1.5 | 0.28 | 1.5 | 0.33 |
|
| — |
| Growth factor receptor bound protein 10 |
| NM_010345 | 1.5 | 0.08 | — | ||||
| Insulin receptor substrate 1 |
| NM_010570 |
|
| 1.3 | 0.07 |
|
| — |
| Protein tyrosine phosphatase, receptor type, F |
| NM_011213 |
|
|
|
| — | ||
| Scr homology 2 domain containing transforming protein C1 |
| NM_011368 |
|
| — | ||||
|
| |||||||||
| Glucose-6-phosphatase, catalytic, 2 |
| NM_021331 | −3.2 | 0.08 | — | ||||
| Insulin-like growth factor 2 |
| NM_010514 | −1.2 | 0.21 |
|
| — | ||
| V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
| NM_021284 | −1.1 | 0.09 |
|
| — | ||
| Protein kinase C, iota |
| NM_008857 |
|
|
|
| CT0 | ||
| Thyroglobulin |
| NM_009375 | −1.8 | 0.29 |
|
| — | ||
Differentially expressed genes from adipogenesis pathway of Id2−/− mice. Genes with significant differences (p < 0.05) are shown in bold.
| Adipogenesis array | Symbol | Refseq | All | Male | Female | Clock control gene-peak phase | |||
|---|---|---|---|---|---|---|---|---|---|
| Fold change |
| Fold change |
| Fold change |
| ||||
|
| |||||||||
| Bone morphogenetic protein 4 |
| NM_007554 |
|
| 1.7 | 0.12 |
|
| — |
| Complement factor D (adipsin) |
| NM_013459 |
|
|
|
| — | ||
| Insulin receptor substrate 1 |
| NM_010570 |
|
| 1.1 | 0.29 |
|
| — |
| TSC22 domain family, member 3 |
| NM_010286 |
|
| 1.9 | 0.09 | CT16 | ||
|
| |||||||||
| Axin 1 |
| NM_009733 | −1.2 | 0.07 |
|
| — | ||
| Cyclin-dependent kinase 4 |
| NM_009870 |
|
|
|
| CT6 | ||
| Delta-like 1 homolog (Drosophila) |
| NM_010052 |
|
|
|
| — | ||
| Fatty acid synthase |
| NM_007988 | −1.2 | 0.06 |
|
| — | ||
| Lipase, hormone sensitive |
| NM_010719 | −1.2 | 0.06 |
|
| — | ||
| Nuclear receptor coactivator 2 |
| NM_008678 | −1.2 | 0.07 | −1.3 | 0.07 | — | ||
| Peroxisome proliferator activated receptor alpha |
| NM_011144 |
|
| −2.3 | 0.06 | −1.7 | 0.09 | CT6 |
| Peroxisome proliferator activated receptor gamma |
| NM_011146 | −1.2 | 0.06 | |||||
| Peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
| NM_008904 | −1.2 | 0.09 |
|
| CT8 | ||
| Peroxisome proliferative activated receptor, gamma, coactivator 1 beta |
| NM_133249 |
|
|
|
| CT5 | ||
| PR domain containing 16 |
| NM_027504 |
|
|
|
| — | ||
| Twist homolog 1 (Drosophila) |
| NM_011658 |
|
| −2.0 | 0.06 |
|
| — |
| Actin, beta |
| NM_007393 |
|
|
|
| — | ||
Figure 3Id2 network model in insulin signaling, thermogenesis, and adipogenesis pathways. A schematized and partial view of the signaling pathway indicating its major downstream targets and factors susceptible to interfering with signaling. Function of ID2 is not necessarily limited to the nucleus [8]. ↑ or ↓, up- or downregulation of gene expression, respectively, as determined by PCR array analysis in the current study.